Please use this identifier to cite or link to this item:
|Title:||Rare sudden unexpected death in epilepsy SCN5A variants cause changes in channel function implicating cardiac arrhythmia as a cause of death.||Austin Authors:||Soh, Ming S;Bagnall, Richard D;Semsarian, Christopher;Scheffer, Ingrid E ;Berkovic, Samuel F ;Reid, Christopher A||Affiliation:||Department of Paediatrics, University of Melbourne, Royal Children's Hospital, Victoria, Australia..
Epilepsy Research Centre
The Florey Institute of Neuroscience and Mental Health
Agnes Ginges Centre for Molecular Cardiology, Centenary Institute, University of Sydney, Sydney, New South Wales, Australia..
Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia..
Murdoch Children's Research Institute, Royal Children's Hospital, Parkville, Victoria, Australia..
|Issue Date:||Jun-2022||metadata.dc.date:||2022||Publication information:||Epilepsia 2022; 63(6): e57-e62||Abstract:||Sudden unexpected death in epilepsy (SUDEP) is a leading cause of premature death in epilepsy. The underlying pathological mechanisms are likely to be multifactorial. Cardiac arrhythmia has been suggested as a cause of death in some patients with SUDEP. SCN5A encodes the cardiac Nav 1.5 sodium channel. SCN5A variants that result in either loss or gain of channel function cause cardiac arrhythmias. Rare SCN5A variants have been reported in SUDEP cases, but the impact of these variants on channel function is unknown. Here, we use whole-cell voltage clamp recordings to perform functional analyses of rare SCN5A SUDEP variants, p.V223G, p.I397V, and p.R523C. Expression and biophysical properties, including activation, inactivation, and recovery from inactivation, were probed. Each SCN5A variant significantly impacted human NaV 1.5 channel function, indicating that they could cause cardiac arrhythmias. The patient carrying the p.R523C variant was on lamotrigine, an antiseizure medication implicated in SUDEP. Therapeutic concentration of lamotrigine caused a slowing of the rate of recovery from inactivation and a hyperpolarizing shift in the voltage of inactivation of human NaV 1.5 wild-type, but not p.R523C channels, implicating a gene-by-drug interaction. These data suggest that SCN5A arrhythmogenic variants may confer increased risk of sudden death in individuals with epilepsy.||URI:||https://ahro.austin.org.au/austinjspui/handle/1/30352||DOI:||10.1111/epi.17254||ORCID:||https://orcid.org/0000-0002-5689-2082
|Journal:||Epilepsia||PubMed URL:||35397174||PubMed URL:||https://pubmed.ncbi.nlm.nih.gov/35397174/||Type:||Journal Article||Subjects:||SUDEP
|Appears in Collections:||Journal articles|
Show full item record
checked on Jun 9, 2023
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.